84 related articles for article (PubMed ID: 19691429)
21. Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter?
Delwart E
Transfusion; 2012 Jul; 52(7):1398-403. PubMed ID: 22780892
[No Abstract] [Full Text] [Related]
22. Parvovirus 4 infection and clinical outcome in high-risk populations.
Simmons R; Sharp C; McClure CP; Rohrbach J; Kovari H; Frangou E; Simmonds P; Irving W; Rauch A; Bowness P; Klenerman P;
J Infect Dis; 2012 Jun; 205(12):1816-20. PubMed ID: 22492853
[TBL] [Abstract][Full Text] [Related]
23. Human parvovirus 4 infection, Cameroon.
Lavoie M; Sharp CP; Pépin J; Pennington C; Foupouapouognigni Y; Pybus OG; Njouom R; Simmonds P
Emerg Infect Dis; 2012 Apr; 18(4):680-3. PubMed ID: 22469425
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
25. From orphan virus to pathogen: the path to the clinical lab.
Li L; Delwart E
Curr Opin Virol; 2011 Oct; 1(4):282-8. PubMed ID: 22003378
[TBL] [Abstract][Full Text] [Related]
26. Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan.
Chen MY; Yang SJ; Hung CC
Emerg Infect Dis; 2011 Oct; 17(10):1954-6. PubMed ID: 22000381
[TBL] [Abstract][Full Text] [Related]
27. Human parvovirus 4 as potential cause of encephalitis in children, India.
Benjamin LA; Lewthwaite P; Vasanthapuram R; Zhao G; Sharp C; Simmonds P; Wang D; Solomon T
Emerg Infect Dis; 2011 Aug; 17(8):1484-7. PubMed ID: 21801629
[TBL] [Abstract][Full Text] [Related]
28. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.
Simmons R; Sharp C; Sims S; Kloverpris H; Goulder P; Simmonds P; Bowness P; Klenerman P
J Infect Dis; 2011 May; 203(10):1378-87. PubMed ID: 21502079
[TBL] [Abstract][Full Text] [Related]
29. Serodiagnosis of primary infections with human parvovirus 4, Finland.
Lahtinen A; Kivelä P; Hedman L; Kumar A; Kantele A; Lappalainen M; Liitsola K; Ristola M; Delwart E; Sharp C; Simmonds P; Söderlund-Venermo M; Hedman K
Emerg Infect Dis; 2011 Jan; 17(1):79-82. PubMed ID: 21192859
[TBL] [Abstract][Full Text] [Related]
30. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
Corcioli F; Zakrzewska K; Fanci R; De Giorgi V; Innocenti M; Rotellini M; Di Lollo S; Azzi A
Virol J; 2010 Oct; 7():272. PubMed ID: 20950445
[TBL] [Abstract][Full Text] [Related]
31. Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa.
Sharp CP; Vermeulen M; Nébié Y; Djoko CF; LeBreton M; Tamoufe U; Rimoin AW; Kayembe PK; Carr JK; Servant-Delmas A; Laperche S; Harrison GL; Pybus OG; Delwart E; Wolfe ND; Saville A; Lefrère JJ; Simmonds P
Emerg Infect Dis; 2010 Oct; 16(10):1605-7. PubMed ID: 20875290
[TBL] [Abstract][Full Text] [Related]
32. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.
Sharp CP; LeBreton M; Kantola K; Nana A; Diffo Jle D; Djoko CF; Tamoufe U; Kiyang JA; Babila TG; Ngole EM; Pybus OG; Delwart E; Delaporte E; Peeters M; Soderlund-Venermo M; Hedman K; Wolfe ND; Simmonds P
J Virol; 2010 Oct; 84(19):10289-96. PubMed ID: 20668071
[TBL] [Abstract][Full Text] [Related]
33. Novel human parvovirus 4 genotype 3 in infants, Ghana.
Panning M; Kobbe R; Vollbach S; Drexler JF; Adjei S; Adjei O; Drosten C; May J; Eis-Hubinger AM
Emerg Infect Dis; 2010 Jul; 16(7):1143-6. PubMed ID: 20587191
[TBL] [Abstract][Full Text] [Related]
34. Parvovirus 4-like virus in blood products.
Szelei J; Liu K; Li Y; Fernandes S; Tijssen P
Emerg Infect Dis; 2010 Mar; 16(3):561-4. PubMed ID: 20202447
[TBL] [Abstract][Full Text] [Related]
35. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
37. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
[TBL] [Abstract][Full Text] [Related]
38. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus transmission by blood products - a cause for concern?
Norja P; Lassila R; Makris M
Br J Haematol; 2012 Nov; 159(4):385-93. PubMed ID: 23025427
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]